ASX Announcement | 27/07/2020 |
Results of Hydrix Non-Renounceable Entitlement Offer
Hydrix Limited (ASX: HYD) (Hydrix or Company) is pleased to announce the successful completion of its fully underwritten pro-ratanon-renounceable entitlement offer announced to the market on 6 July 2020, to raise approximately $2 million (before costs) (Entitlement Offer).
Under the Entitlement Offer, eligible shareholders were entitled to subscribe for 1 new fully paid ordinary share in Hydrix (Share) for every 3 Shares held on the record date of 7.00pm (AEST) on Thursday, 9 July 2020 (Record Date), at an issue price of 7.5 cents per Share. For every 3 new Shares validly subscribed for under the Entitlement Offer, eligible shareholders were also entitled to receive 1 free option to acquire a Share, exercisable at 12 cents on or before 31 July 2022 (Entitlement Option).
Eligible shareholders were also able to apply for any Shares offered under the Entitlement Offer which were not validly applied for by shareholders under their respective entitlements (Shortfall Facility).
Results of Entitlement Offer
The Entitlement Offer, which closed at 5.00pm (AEST) on Thursday 23 July 2020, was oversubscribed with a total of 28 million Shares (to the value of $2.1 million) applied for under the Entitlement and Shortfall Facility components of the offer. The final application numbers were as follows:
No. of Shares | Subscription funds | |||
Applications under Entitlement component of Entitlement Offer | 9,607,412 | $720,556 | ||
Applications under Shortfall Facility component of Entitlement | 18,456,683 | $1,384,251 | ||
Offer | ||||
Total Applications | $2,104,807 | |||
Scale-back of Applications under Shortfall Facility
As disclosed in Hydrix's prospectus dated 6 July 2020 (Prospectus), Hydrix only intends to issue up to the aggregate number of new Shares that were offered under the Entitlement Offer, and in the event of an over-subscription under the Shortfall Facility, Hydrix reserves the right, in consultation with the underwriter of the Entitlement Offer, Henslow Pty Ltd (Underwriter), to give priority to the Underwriter and sub- underwriters in allocating any shortfall.
In consultation with the Underwriter, Hydrix has determined to scale-back applications for additional new Shares under the Shortfall Facility (Shortfall Applications) in the following manner:
- The value of Shortfall Applications will be scaled back to 29% of the total amount applied for under those Shortfall Applications (such that Shares to the value of $0.40 million will be allocated to applicants under the Shortfall Facility (each a Shortfall Applicant));
- If a Shortfall Applicant applied for less than 7,000 Shares (valued at $525) under the Shortfall Facility, the Shortfall Applicant will receive the full number of Shares applied for under the Shortfall Facility; and
Hydrix Limited | 30-32 Compark Circuit | T+ 61 3 9550 8100 | W: www.hydrix.com |
ACN 060 369 048 | Mulgrave VIC 3170 | E: info@hydrix.com |
ASX Announcement | 27/07/2020 |
- A pro-rata scale back (based on the number of Shares held as at the Record Date) will be applied to all Shortfall Applicants who applied for more than 7,000 Shares under the Shortfall Facility, subject to a minimum allocation of at least 7,000 Shares.
All shortfall Shares remaining after implementation of the above scale-back policy will be allocated to the Underwriter and sub-underwriters.
Underwriter Offer
The Entitlement Offer was fully underwritten by Henslow Pty Ltd. Under the terms of the underwriting agreement, the Company has agreed to issue the following options, on the same terms as the Entitlement Options (Underwriter Options):
- One Underwriter Option for every 3 Shares sub-underwritten, to sub-underwriters of the Entitlement Offer; and
- 3 million Options to the Underwriter.
The Underwriter Offer closed at 5.00pm (AEST) on Thursday 23 July 2020, with a total of 11,847,320 Underwriter Options validly applied for under the Underwriter Offer.
Issue of new securities
Hydrix will issue and allot the following new securities under the Entitlement Offer and Underwriter Offer on Thursday, 30 July 2020:
No. of new | No. of new | Subscription | |
Shares | Options1 | funds | |
Entitlement Offer | |||
To be issued under Entitlement component | 9,607,412 | 3,202,471 | $720,556 |
To be issued under Shortfall Facility component | 5,371,447 | 1,790,482 | $402,859 |
To be issued under to Underwriter and sub-underwriters | 11,563,100 | 3,854,367 | $867,233 |
Sub-total | 26,541,959 | 8,847,320 | $1,990,648 |
Underwriter Offer | |||
To be issued to Underwriter | 0 | 3,000,000 | $50 |
To be issued to sub-underwriters | 0 | 8,847,320 | $0 |
Sub-total | 0 | 11,846,919 | $50 |
Total | 26,541,959 | 20,694,238 | $1,990,698 |
The new securities issued under the Entitlement and Underwriter Offer shares are expected to commence trading on ASX on Friday 31 July 2020.
Holding statements will be dispatched to successful applicants and refunds for application monies where applications were scaled back will be processed on or around Monday 3 August 2020.
1 The number of Entitlement Options and Underwriter Options to be issued is subject to rounding for fractional entitlements.
Hydrix Limited | 30-32 Compark Circuit | T+ 61 3 9550 8100 | W: www.hydrix.com |
ACN 060 369 048 | Mulgrave VIC 3170 | E: info@hydrix.com |
ASX Announcement | 27/07/2020 |
Placement Offer Update
As disclosed under the Prospectus, Hydrix is seeking to raise an additional $1 million (before costs) through the issue of new Shares to sophisticated and professional investors, at the same issue price of 7.5 cents per Share (Placement Offer). For every 3 new Shares subscribed for under the Placement Offer, investors will receive 1 free option to acquire a Share, on the same terms as the Entitlement Options issued under the Entitlement Offer. Hydrix has received binding commitments from investors to subscribe for Shares under the Placement Offer.
Completion of the Placement Offer is subject to shareholder approval under ASX Listing Rule 7.1, which the Company intends to seek at a general meeting to be convened in early September 2020. Further details of this meeting will be set out in a Notice of Meeting to be lodged with ASX in the coming weeks.
-ENDS-
Authorisation: This announcement has been authorised by the Board of Hydrix Limited.
Contact details: For more information, please contact:
Company enquiries: | Investor enquiries: | Media Enquires |
Alyn Tai | Justin Lewis | Rod North |
Company Secretary | Henslow | Bourse Communications |
Alyn.Tai@hydrix.com | jlewis@henslow.com | rod@boursecommunications.com.au |
+61 3 9321 9834 | +61 3 8622 3313 | +61 3 9510 8309 |
About Hydrix Limited
Hydrix Limited (ASX: HYD) is a powerful product innovation company. We leverage our product innovation capability across multiple growth platforms. These platforms include Hydrix Services design and engineering to create products which transform markets; Hydrix Ventures to pick winning investments in high potential innovative products; and Hydrix Medical to create new product revenue streams bringing cardiovascular technologies to market.
Hydrix Limited | 30-32 Compark Circuit | T+ 61 3 9550 8100 | W: www.hydrix.com |
ACN 060 369 048 | Mulgrave VIC 3170 | E: info@hydrix.com |
